<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals Ltd has informed BSE that it does not qualify as a 'Large Corporate' under the SEBI circular dated November 26, 2018. This is because the company's outstanding long-term borrowing was less than Rs. 100 crore as on March 31, 2025. As a result, the compliance framework meant for Large Corporates regarding debt security issuance does not apply to the company. The disclosure was filed on April 28, 2025, signed by Director Suraj Chagan Solanki. This is a routine annual compliance filing.
No impact on shareholders or stock price. This is a standard regulatory disclosure confirming that the company is a small entity by SEBI's borrowing threshold and is exempt from additional large-corporate borrowing obligations.